首页> 美国卫生研究院文献>OMICS : a Journal of Integrative Biology >Medium-Term Variability of the Human Serum Metabolome in the Atherosclerosis Risk in Communities (ARIC) Study
【2h】

Medium-Term Variability of the Human Serum Metabolome in the Atherosclerosis Risk in Communities (ARIC) Study

机译:人类血清代谢组在社区动脉粥样硬化风险中的中期变异性(ARIC)研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Metabolomics is a systems biology tool providing small molecule signatures of disease etiology. In order to estimate the biologic variability of the human serum metabolome, this study calculated intraclass correlation coefficients (ICCs) for 178 stably-detected metabolites measured by untargeted chromatography/mass spectrometry. We studied a subsample of 60 participants (57% males, 70% Caucasians, aged 73.77±5.3 years) in the Atherosclerosis Risk in Communities (ARIC) Study who provided two fasting serum samples 4–6 weeks apart. The median ICC across all metabolites was 0.60, and 82% of metabolites had at least fair variability (i.e., ICC>= 0.40). There was variation in the medium-term variability among metabolites, with those in the pathways of amino acid and lipid metabolism showing relatively high ICCs, and those in the carbohydrate pathway showing relatively low ICCs. The results of this study provide a valuable resource for future study design and outcome interpretation of mass spectrometry-based metabolomic studies in epidemiology.
机译:代谢组学是一种系统生物学工具,可提供疾病病因的小分子特征。为了评估人血清代谢组的生物学变异性,本研究计算了通过无目标色谱/质谱法测量的178种稳定检测的代谢物的类内相关系数(ICC)。我们在社区动脉粥样硬化风险研究(ARIC)中研究了60名参与者(57%的男性,70%的白种人,73.77±5.3岁)的子样本,他们提供了两个间隔4-6周的空腹血清样本。所有代谢产物的ICC中位数为0.60,82%的代谢产物至少具有合理的变异性(即ICC> = 0.40)。代谢物之间的中期变异性存在差异,氨基酸和脂质代谢途径中的代谢物具有较高的ICC,而碳水化合物途径中的代谢物具有较低的ICC。这项研究的结果为流行病学中基于质谱的代谢组学研究的未来研究设计和结果解释提供了宝贵的资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号